RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Advanz Pharma Corp Stock

Advanz Pharma Corp Net Income 2024

Advanz Pharma Corp Net Income

-15.51 B USD

Ticker

CXRXF

ISIN

JE00BJVH6L55

WKN

A2PYQF

In 2024, Advanz Pharma Corp's profit amounted to -15.51 B USD, a 20,613.32% increase from the -74.86 M USD profit recorded in the previous year.

The Advanz Pharma Corp Net Income history

YEARNET INCOME (undefined USD)
2021e-15.51
2020-0.07
2019-0.2
20181.47
2017-1.59
2016-1.32
2015-0.03

Advanz Pharma Corp Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Advanz Pharma Corp, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Advanz Pharma Corp from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Advanz Pharma Corp’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Advanz Pharma Corp. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Advanz Pharma Corp’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Advanz Pharma Corp’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Advanz Pharma Corp’s growth potential.

Advanz Pharma Corp Revenue, EBIT and net profit per share

DateAdvanz Pharma Corp RevenueAdvanz Pharma Corp EBITAdvanz Pharma Corp Net Income
2021e402.28 M undefined0 undefined-15.51 B undefined
2020525.58 M undefined29.77 M undefined-74.86 M undefined
2019508.32 M undefined23.09 M undefined-196.02 M undefined
2018536.99 M undefined-4.35 M undefined1.47 B undefined
2017626.17 M undefined78 M undefined-1.59 B undefined
2016816.16 M undefined231.22 M undefined-1.32 B undefined
2015394.22 M undefined138.22 M undefined-31.57 M undefined

Advanz Pharma Corp stock margins

The Advanz Pharma Corp margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Advanz Pharma Corp. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Advanz Pharma Corp.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Advanz Pharma Corp's sales revenue. A higher gross margin percentage indicates that the Advanz Pharma Corp retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Advanz Pharma Corp's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Advanz Pharma Corp's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Advanz Pharma Corp's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Advanz Pharma Corp. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Advanz Pharma Corp's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Advanz Pharma Corp Margin History

Advanz Pharma Corp Gross marginAdvanz Pharma Corp Profit marginAdvanz Pharma Corp EBIT marginAdvanz Pharma Corp Profit margin
2021e63.41 %0 %-3,854.42 %
202063.41 %5.66 %-14.24 %
201966.26 %4.54 %-38.56 %
201867.25 %-0.81 %273.25 %
201769.56 %12.46 %-254.04 %
201672.9 %28.33 %-161.21 %
201576.08 %35.06 %-8.01 %

Advanz Pharma Corp Aktienanalyse

What does Advanz Pharma Corp do?

Advanz Pharma Corp Ltd is an international pharmaceutical company that focuses on the development, manufacturing, and marketing of generics and specialty pharmaceuticals. The company is headquartered in London and operates numerous subsidiaries worldwide. Answer: Advanz Pharma Corp Ltd is an international pharmaceutical company that specializes in developing, manufacturing, and marketing generics and specialty pharmaceuticals. It was founded in 2015 through the merger of two well-known generic drug manufacturers: Canadian company Concordia International Corp and Irish company Warner Chilcott plc. Advanz Pharma is listed on the Bombay Stock Exchange and the National Stock Exchange of India since 2017. Answer: Advanz Pharma has its own business model that emphasizes the marketing and development of generics and specialty pharmaceuticals. The company focuses on providing cost-effective medical solutions by producing generic versions of products whose patent has expired or is about to expire. These medications are typically more affordable than their original counterparts. However, the company also manufactures specialty pharmaceuticals that specialize in rare diseases, oncology, and hormonal disorders. Answer: Advanz Pharma is divided into several divisions to produce various types of medications, such as: - Cardiology - Oncology - Gastroenterology - Neurology - Antibiotics - Diabetic care - Endocrinology and reproduction Answer: Advanz Pharma manufactures a wide range of generics and specialty pharmaceuticals. Some of the products include: - Metformin, an antidiabetic medication - Carbidopa/levodopa, a medication for treating Parkinson's disease - Ezetimibe, for lowering cholesterol levels - Doxorubicin, a cancer medication - Hydroxyzine, an antiallergic medication - Methotrexate, a cancer and rheumatoid arthritis medication Answer: In conclusion, Advanz Pharma Corp Ltd is an international generics and specialty pharmaceutical company that focuses on the development, manufacturing, and marketing of cost-effective medications. The company has a broad product portfolio that includes both generics and specialized medications. It aims to provide cost-effective solutions to improve access to essential healthcare. Advanz Pharma Corp ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Net Income Details

Understanding Advanz Pharma Corp's Profit Margins

The profit margins of Advanz Pharma Corp represent the net income earned after deducting all operational expenses, costs, and taxes from the revenue. This figure is a clear indicator of Advanz Pharma Corp's financial health, operational efficiency, and profitability. Higher profit margins signify better cost management and income generation capabilities.

Year-to-Year Comparison

Evaluating Advanz Pharma Corp's profit on a yearly basis can offer significant insights into its financial growth, stability, and trends. A consistent increase in profit suggests improved operational efficiency, cost management, or increased revenue, while a decrease may indicate rising costs, declining sales, or operational challenges.

Impact on Investments

Advanz Pharma Corp's profit figures are critical for investors who are aiming to understand the company's financial standing and future growth prospects. Increased profits often lead to higher stock valuations, boosting investor confidence and attracting more investments.

Interpreting Profit Fluctuations

When Advanz Pharma Corp’s profit increases, it often indicates enhanced operational efficiency or increased sales. In contrast, a decline in profit can signal operational inefficiencies, increased costs, or competitive pressures, necessitating strategic interventions to boost profitability.

Frequently Asked Questions about Advanz Pharma Corp stock

How much profit has Advanz Pharma Corp made this year?

Advanz Pharma Corp has made -15.51 B USD this year.

How has the profit developed compared to last year?

The profit has increased by 20,613.32% compared to last year increased

What impact do the earnings have on the shareholders?

An increase in earnings is usually seen as a positive indicator for shareholders as it means that the company is generating profits.

How does Advanz Pharma Corp publish its earnings?

Advanz Pharma Corp publishes its earnings in the form of quarterly or annual reports.

Which financial indicators are included in the quarterly or annual reports?

The quarterly or annual reports contain information about sales and profit, cash flow, balance sheet, and other fundamentals.

Why is it important for investors to know the earnings of Advanz Pharma Corp?

The profits of Advanz Pharma Corp are an important indicator of the financial health of the company and can help investors decide whether they want to invest in the company or not.

How can one learn more about the earnings of Advanz Pharma Corp?

You can learn more about the earnings of Advanz Pharma Corp by reviewing the quarterly or annual reports or following the company presentations.

How much dividend does Advanz Pharma Corp pay?

Over the past 12 months, Advanz Pharma Corp paid a dividend of 67.5 USD . This corresponds to a dividend yield of about 395.66 %. For the coming 12 months, Advanz Pharma Corp is expected to pay a dividend of 0 USD.

What is the dividend yield of Advanz Pharma Corp?

The current dividend yield of Advanz Pharma Corp is 395.66 %.

When does Advanz Pharma Corp pay dividends?

Advanz Pharma Corp pays a quarterly dividend. This is distributed in the months of November, February, May, August.

How secure is the dividend of Advanz Pharma Corp?

Advanz Pharma Corp paid dividends every year for the past 0 years.

What is the dividend of Advanz Pharma Corp?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Advanz Pharma Corp located?

Advanz Pharma Corp is assigned to the 'Health' sector.

Wann musste ich die Aktien von Advanz Pharma Corp kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Advanz Pharma Corp from 7/29/2016 amounting to 0.075 USD, you needed to have the stock in your portfolio before the ex-date on 7/13/2016.

When did Advanz Pharma Corp pay the last dividend?

The last dividend was paid out on 7/29/2016.

What was the dividend of Advanz Pharma Corp in the year 2023?

In the year 2023, Advanz Pharma Corp distributed 0 USD as dividends.

In which currency does Advanz Pharma Corp pay out the dividend?

The dividends of Advanz Pharma Corp are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Advanz Pharma Corp

Our stock analysis for Advanz Pharma Corp Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Advanz Pharma Corp Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.